| 1 |
Kuroda S, Iwasaki Y. Current review of familial moyamoya disease [J]. Nippon Rinsho, 2006, 64(Suppl 8): 750-754.
|
| 2 |
Scott RM, ER S. Moyamoya disease and moyamoya syndrome [J]. N Engl J Med, 2009, 360: 1226-1237.
|
| 3 |
Graham JF, Matoba A. A survey of Moyamoya disease in Hawaii [J]. Clin Neurol Neurosurg, 1997, 99(Suppl 2): S31-S35.
|
| 4 |
Numaguchi Y, Gonzalez CF, Davis PC, et al. Moyamoya disease in the United States [J]. Clin Neurol Neurosurg, 1997, 99(Suppl 2): S26-S30.
|
| 5 |
Wetjen NM, Garell PC, Stence NV, et al. Moyamoya disease in the midwestern United States [J]. Neurosurg Focus, 1998, 5(5): e1.
|
| 6 |
Chiu D, Shedden P, Bratina P, et al. Clinical features of moyamoya disease in the United States [J]. Stroke, 1998, 29(7): 1347-1351.
|
| 7 |
Uchino K, Johnston SC, Becker KJ, et al. Moyamoya disease in Washington state and California [J]. Neurology, 2005, 65(6): 956-958.
|
| 8 |
Lee DJ, Liebeskind DS. Characterization of inpatient moyamoya in the United States: 1988-2004 [J]. Front Neurol, 2011, 2: 43.
|
| 9 |
Starke RM, Crowley RW, Maltenfort M, et al. Moyamoya disorder in the United states [J]. Neurosurgery, 2012, 71(1): 93-99.
|
| 10 |
Kainth D, Chaudhry SA, Kainth H, et al. Epidemiological and clinical features of moyamoya disease in the USA [J]. Neuroepidemiology, 2013, 40(4): 282-287.
|
| 11 |
Yonekawa Y, Ogata N, Kaku Y, et al. Moyamoya disease in Europe, past and present status [J]. Clin Neurol Neurosurg, 1997, 99(Suppl 2): S58-S60.
|
| 12 |
Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans [J]. Stroke, 2008, 39(12): 3193-3200.
|
| 13 |
Acker G, Goerdes S, Schneider UC, et al. Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians [J]. Eur J Neurol, 2015, 22(6): 1012-1017.
|
| 14 |
Birkeland P, Lauritsen J. Incidence of moyamoya disease in Denmark: a population-based register study [J]. Acta Neurochir Suppl, 2018, 129: 91-93.
|
| 15 |
Annual report of the research committee on epidemiology of intractable diseases. the research committee on epidemiology of intractable diseases [R]. Tochigi, Japan, 1991.
|
| 16 |
Wakai K, Tamakoshi A, Ikezaki K. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey [J]. Clin Neurol Neurosurg, 1997, 99(Suppl 2): S1-S5.
|
| 17 |
Ikezaki K, Han DH, Kawano T, et al. A clinical comparison of definite moyamoya disease between South Korea and Japan [J]. Stroke, 1997, 28(12): 2513-2517.
|
| 18 |
Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey [J]. Stroke, 2008, 39(1): 42-47.
|
| 19 |
Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease [J]. J Neurol Neurosurg Psychiatry, 2008, 79(8): 900-904.
|
| 20 |
Hoshino H, Izawa Y, Suzuki N, et al. Epidemiological features of moyamoya disease in Japan [J]. Neurol Med Chir (Tokyo), 2012, 52(5): 295-208.
|
| 21 |
Sato Y, Kazumata K, Nakatani E, et al. Characteristics of moyamoya disease based on national registry data in Japan [J]. Stroke, 2019, 50(8): 1973-1980.
|
| 22 |
Han DH, Kwon OK, Byun BJ, et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease [J]. Acta Neurochir (Wien), 2000, 142(11): 1263-1273.
|
| 23 |
Im SH, Cho CB, Joo WI, et al. Prevalence and epidemiological features of moyamoya disease in Korea [J]. J Cerebrovasc Endovasc Neurosurg, 2012, 14(2): 75-78.
|
| 24 |
Ahn IM, Park DH, Hann HJ, et al. Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study [J]. Stroke, 2014, 45(4): 1090-1095.
|
| 25 |
Kim T, Lee H, Bang JS, et al. Epidemiology of moyamoya disease in Korea: based on national health insurance service data [J]. J Korean Neurosurg Soc, 2015, 57(6): 390-395.
|
| 26 |
Huang CC, Tu YK, Su CF, et al. Epidemiological study of moyamoya disease in Taiwan, China [J]. Clin Neurol Neurosurg, 1997, 99(Suppl 2): S23-S25.
|
| 27 |
Chen PC, Yang SH, Chien KL, et al. Epidemiology of moyamoya disease in Taiwan, China [J]. Stroke, 2014, 45(5): 1258-1263.
|
| 28 |
Miao W, Zhao PL, Zhang YS, et al. Epidemiological and clinical features of Moyamoya disease in Nanjing, China [J]. Clin Neurol Neurosurg, 2010, 112(3): 199-203.
|
| 29 |
Duan L, Bao XY, Yang WZ, et al. Moyamoya disease in China: its clinical features and outcomes [J]. Stroke, 2012, 43(1): 56-60.
|
| 30 |
Bao XY, Wang QN, Zhang Y, et al. Epidemiology of moyamoya disease in China: single-center, population-based study [J]. World Neurosurg, 2019, 122: e917-e923.
|
| 31 |
Goto Y, Yonekawa Y. Worldwide distribution of Moyamoya disease [J]. Neurol Med Chir (Tokyo), 1992, 32(12): 883-886.
|
| 32 |
Ikeda K, Iwasaki Y, Kashihara H, et al. Adult moyamoya disease in the asymptomatic Japanese population [J]. J Clin Neurosci, 2006, 13(13): 334-338.
|
| 33 |
Hayashi K, Horie N, Suyama K, et al. An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan [J]. Clin Neurol Neurosurg, 2013, 115(7): 930-933.
|
| 34 |
Olds MV, Griebel RW, Hoffman HJ, et al. The surgical treatment of childhood moyamoya disease[J]. J Neurosurg, 1987, 66(5): 675-680.
|
| 35 |
Nanba R, Kuroda S, Tada M, et al. Clinical features of familial moyamoya disease [J]. Childs Nerv Syst, 2006, 22(3): 258-262.
|
| 36 |
Fujimura M, Bang OY, Kim JS. Moyamoya disease [J]. Front Neurol Neurosci, 2016, 40: 204-220.
|
| 37 |
Shang S, Zhou D, Ya J, et al. Progress in moyamoya disease [J]. Neurosurg Rev, 2020, 43(2): 371-382.
|
| 38 |
Hallemeier CL, Rich KM, Grubb RL, et al. Clinical features and outcome in north American adults with moyamoya phenomenon [J]. Stroke, 2006, 37(6): 1490-1496.
|
| 39 |
Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis [J]. J Neurosurg, 2004, 100(2 Suppl Pediatrics): 142-149.
|
| 40 |
Liu XJ, Zhang D, Wang S, et al. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China [J]. J Neurosurg, 2015, 122(2): 392-399.
|
| 41 |
Deng X, Gao F, Zhang D, et al. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study [J]. J Neurosurg, 2018, 128(5): 1327-1337.
|